Clinical Trial of Sodium Bicarbonate to Prevent Contrast-Induced Nephropathy

• Status: Unknown status
• Trial end date: 2007-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether sodium bicarbonate is effective in the prevention of sodium-induced nephropathy

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Instituto Nacional de Cardiologia Ignacio Chavez

Criteria

Inclusion Criteria:

• Age over 18 years old

• Indication for coronariography and/or percutaneous coronary intervention

• Voluntary written consent for the realization of coronariography and/or percutaneous intervention and for the participation in this clinical trial

• A MEHRAN contrast-induced nephropathy score of six or more

Exclusion Criteria:

• Patients with chronic kidney failure requiring any kind of dialysis

• Patients unable to complete follow-up

• Multiple myeloma

• Exposure to contrast 48 hours prior to study

• Pregnancy

• Patients unable to give consent

• Already receiving sodium bicarbonate solutions

• Receiving contrast media other than non-ionic